Jonathan D. Santoro, MD News

CHLA’s Neurology and Neurosurgery faculty have led multiple research publications over the past few months.

When athlete Darci suddenly became catatonic, her mom learned of a new Down syndrome regression disorder treatment at CHLA that is bringing her back to herself.

New immunotherapy treatment is bringing hope to families devastated by DSRD.

Jonathan Santoro, MD, is pioneering a novel treatment—and the first clinical trial— for Down syndrome regression disorder, a devastating condition in young people with Down syndrome.

A neuroimmunologist at Children’s Hospital Los Angeles led an effort to create an ICD-10 code for MOGAD—helping to speed access to critical medications.

Children’s Hospital Los Angeles is leading a pioneering study to find new treatments for a devastating condition in Down syndrome.

An experimental treatment for Down syndrome regression disorder is helping one young teen recover her ability to function in the world.

This rare neurological condition requires specialized treatment and may have a link to COVID-19.

Jonathan Santoro, MD, shares his team’s latest research and fellowship—and why he’s in a ‘race’ to discover new approaches to care.

New study aims to better diagnose and understand neurocognitive disability in youth with multiple sclerosis.